Results 11 to 20 of about 1,313 (182)
Effectiveness of extracorporeal photochemotherapy in the treatment of a case of refractory erosive lichen planus [PDF]
, 2009 A. Zingoni +3 more
openalex +4 more sources
Is there a future for extracorporeal photochemotherapy in the treatment of the rheumatological diseases? [PDF]
Annals of the Rheumatic Diseases, 1997 The list of so called ‘disease modifying agents’ in rheumatoid arthritis now includes methotrexate and cyclosporin A. The efficacy of certain speculative treatments in the rheumatic diseases including antibody based therapies such as anti-tumour necrosis factor1 and anti-ICAM,2 cytokine toxic fusion proteins,3 oral administration of antigens,4 stem ...
M. R. Holbrook, R J Powell
openalex +5 more sources
Mode of action, indications and recommendations on extracorporeal photopheresis (ECP)
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 21, Issue 11, Page 1369-1380, November 2023., 2023 Summary Extracorporeal photopheresis (ECP) has gained importance in the treatment of several diseases. Initially introduced as a new therapeutic modality for the treatment of patients with cutaneous T‐cell lymphoma, the indications for the use of ECP have expanded to include hematology and transplantation immunology.
Ara Cho +2 more
wiley +1 more source
Journal of Cosmetic Dermatology, Volume 22, Issue 9, Page 2434-2439, September 2023., 2023 Abstract Background In cosmetic dermatology, lasers and lights treat a variety of hair and skin conditions, including some that disproportionately affect people of color. Aims Our systematic review aims to understand the representation of participants with skin phototypes 4–6 in cosmetic dermatologic trials studying laser and light devices.
Priya Manjaly +9 more
wiley +1 more source
Extracorporeal photopheresis in the treatment of acute and chronic graft-versus-host disease: A position statement from the Turkish Society of Apheresis (TSA) [PDF]
, 2022 Graft versus host disease (GVHD) is still the most important cause of mortality and morbidity after allogeneic stem cell transplantation. Though perfect response rates are not achieved, steroids are still the first-line treat-ment.
Aksu, Salih +6 more
core +2 more sources
Photodermatology, Photoimmunology &Photomedicine, Volume 39, Issue 5, Page 428-434, September 2023., 2023 Abstract Background Mycosis fungoides (MF) is the most common cutaneous T‐cell lymphoma. Skin‐directed therapies, including phototherapy, are the first‐line treatment modalities. Psoralen plus ultraviolet A light photochemotherapy (PUVA) is quite effective in controlling the disease; however, long‐term adverse effects, particularly carcinogenesis, are ...
Pelin Ertop Doğan +5 more
wiley +1 more source
Immunogenic Cell Death in Hematological Malignancy Therapy
Advanced Science, Volume 10, Issue 13, May 5, 2023., 2023 This article introduces the concept of immunogenic death and current therapy can lead to immunogenic death in hematologic malignancy disease therapy, which will open up new ideas for the diseases treatment. Abstract Although the curative effect of hematological malignancies has been improved in recent years, relapse or drug resistance of hematological ...
Zhaoyun Liu +5 more
wiley +1 more source
Photodermatology, Photoimmunology &Photomedicine, Volume 39, Issue 3, Page 256-262, May 2023., 2023 Abstract Background Ultraviolet (UV) A1 phototherapy is considered a beneficial treatment for various inflammatory, sclerotic, malignant, and other skin conditions. However, the available data regarding its efficacy for different indications, the potential side effects, and the recommended treatment protocols are sparse.
Shachar Ronen +3 more
wiley +1 more source
Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management
American Journal of Hematology, Volume 98, Issue 1, Page 193-209, January 2023., 2023 Abstract Disease Overview Cutaneous T‐cell lymphomas are a heterogenous group of T‐cell neoplasms involving the skin, the majority of which may be classified as Mycosis Fungoides (MF) or Sézary Syndrome (SS). Diagnosis The diagnosis of MF or SS requires the integration of clinical and histopathologic data.
Alexandra C. Hristov +2 more
wiley +1 more source